Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Bacterial extracellular vesicles could revolutionize regenerative medicine but need safety improvements.

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

Ethosomes can safely and effectively deliver various drugs deep into the skin.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Certain gene variations are found in people with polycystic ovary syndrome.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

The FDA rejected a testosterone drug again due to safety concerns.

A woman with hypothyroidism developed an allergy to IV levothyroxine after being resistant to oral forms.

SVF and PRP improve hair loss, but SVF causes more side effects.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

Stopping alcohol after long-term use causes anxiety and changes brain chemicals.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

RCS-01 cell therapy is safe and improves skin gene expression.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Combining glycyrrhizin and UVB light is most effective for improving vitiligo.

The Ysc84/SH3yl1 protein family is important for cell movement and the process of taking in materials by interacting with actin and cell membranes.

The meeting concluded with optimism about increasing research and better management of vitiligo.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Combination therapies might work better for some vitiligo patients, but results vary.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.